The Role of von Willebrand Factor Antigen in Predicting Survival of Patients with HBV-Related Cirrhosis

Figure 3

Comparing vWF-Ag levels between patients with different complications. (a)vWF-Ag levels between patients with or without ascites; (b) vWF-Ag levels between patients with or without hepatic encephalopathy; (c) vWF-Ag levels between patients with or without portal vein thrombosis (PVT); (d) vWF-Ag levels between patients with or without spontaneous bacterial peritonitis (SBP).

(a)

(b)

(c)

(d)